Molecular profiles of schizophrenia in the CNS at different stages of illness

[1]  H. M. Morris,et al.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.

[2]  Hilleke E. Hulshoff Pol,et al.  Progressive Brain Volume Loss in Schizophrenia Over the Course of the Illness: Evidence of Maturational Abnormalities in Early Adulthood , 2008, Biological Psychiatry.

[3]  Pat Levitt,et al.  Molecular Evidence for Increased Expression of Genes Related to Immune and Chaperone Function in the Prefrontal Cortex in Schizophrenia , 2007, Biological Psychiatry.

[4]  M. Mimmack,et al.  Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. , 2007, The international journal of neuropsychopharmacology.

[5]  Stella Dracheva,et al.  Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. , 2007, The international journal of neuropsychopharmacology.

[6]  Leanne M Williams,et al.  Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. , 2007, The American journal of psychiatry.

[7]  Brian Dean,et al.  Gene Expression Profiling in Brodmann's Area 46 from Subjects with Schizophrenia , 2007, The Australian and New Zealand journal of psychiatry.

[8]  T. Ohnishi,et al.  Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging , 2007, Psychiatry Research: Neuroimaging.

[9]  Alan C. Evans,et al.  Focal Gray Matter Changes in Schizophrenia across the Course of the Illness: A 5-Year Follow-Up Study , 2007, Neuropsychopharmacology.

[10]  A. Jeffries,et al.  RE1 Silencing Transcription Factor Maintains a Repressive Chromatin Environment in Embryonic Hippocampal Neural Stem Cells , 2007, Stem cells.

[11]  E. Thomas,et al.  Molecular profiling of antipsychotic drug function , 2006, Molecular Neurobiology.

[12]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[13]  J. Lieberman.  Neurobiology and the natural history of schizophrenia. , 2006, The Journal of clinical psychiatry.

[14]  K. Iwamoto,et al.  Gene Expression Profiling in Schizophrenia and Related Mental Disorders , 2006, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[15]  P. Levitt,et al.  Critical Appraisal of DNA Microarrays in Psychiatric Genomics , 2006, Biological Psychiatry.

[16]  R. Burke,et al.  The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia , 2006, Molecular Psychiatry.

[17]  L. DeLisi,et al.  Understanding structural brain changes in schizophrenia , 2006, Dialogues in clinical neuroscience.

[18]  J. Sutcliffe,et al.  Selective deficits in the expression of striatal‐enriched mRNAs in Huntington's disease , 2006, Journal of neurochemistry.

[19]  Gustavo Turecki,et al.  Genome wide gene expression studies in mood disorders. , 2006, Omics : a journal of integrative biology.

[20]  Vahram Haroutunian,et al.  Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study , 2005, Schizophrenia Research.

[21]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[22]  Alexei A. Sharov,et al.  Gene expression A web-based tool for principal component and significance analysis of microarray data , 2005 .

[23]  B. Wexler,et al.  Neurocognitive Function in Schizophrenia at a 10-Year Follow-Up: A Preliminary Investigation , 2005, CNS Spectrums.

[24]  M. Kurtz.  Neurocognitive impairment across the lifespan in schizophrenia: an update , 2005, Schizophrenia Research.

[25]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[26]  T. Woo,et al.  Targeting synapses and myelin in the prevention of schizophrenia , 2005, Schizophrenia Research.

[27]  C. Aston,et al.  Original Research Article , 2004 .

[28]  K. Davis,et al.  Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. , 2005, International review of neurobiology.

[29]  A. Kakita,et al.  Prefrontal Abnormality of Schizophrenia Revealed by DNA Microarray: Impact on Glial and Neurotrophic Gene Expression , 2004, Annals of the New York Academy of Sciences.

[30]  L. DeLisi,et al.  Cerebral ventricular change over the first 10 years after the onset of schizophrenia , 2004, Psychiatry Research: Neuroimaging.

[31]  E. Steinmeyer,et al.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study , 1989, European archives of psychiatry and neurological sciences.

[32]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..

[33]  Jay N Giedd,et al.  Progressive brain volume loss during adolescence in childhood-onset schizophrenia. , 2003, The American journal of psychiatry.

[34]  Philip D. Harvey,et al.  The course of functional decline in geriatric patients with schizophrenia: cognitive-functional and clinical symptoms as determinants of change. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[35]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[36]  Vincent Magnotta,et al.  Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. , 2003, Archives of general psychiatry.

[37]  Daniel R Weinberger,et al.  Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study , 2002, Schizophrenia Research.

[38]  J. Trojanowski,et al.  Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. , 2002, Archives of general psychiatry.

[39]  J. Pierri,et al.  Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia , 2002, The Journal of Neuroscience.

[40]  J. Kleinman,et al.  Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.

[41]  Emil Kraepelin,et al.  Dementia praecox and paraphrenia , 2002 .

[42]  J. Lieberman,et al.  The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches , 2001, Biological Psychiatry.

[43]  Patricia Desmond,et al.  A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia , 2001, Schizophrenia Research.

[44]  Philip D. Harvey,et al.  Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. , 2001, The American journal of psychiatry.

[45]  P. Brehm,et al.  Regulation of Neuronal Traits by a Novel Transcriptional Complex , 2001, Neuron.

[46]  Cheng Li,et al.  Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application , 2001, Genome Biology.

[47]  M. Webster,et al.  Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium , 2001, Brain Research Bulletin.

[48]  M. Webster,et al.  Application of cDNA microarrays to examine gene expression differences in schizophrenia , 2001, Brain Research Bulletin.

[49]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Y. Sudo,et al.  Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study , 2001, Psychiatry and clinical neurosciences.

[51]  K O Lim,et al.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[52]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[53]  Jeffrey A Lieberman,et al.  Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective , 1999, Biological Psychiatry.

[54]  M. Anderson,et al.  CoREST: a functional corepressor required for regulation of neural-specific gene expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Philip D. Harvey,et al.  Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients , 1999, Biological Psychiatry.

[56]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. McGlashan.  The profiles of clinical deterioration in schizophrenia. , 1998, Journal of psychiatric research.

[58]  P. McHugh,et al.  Long-term follow-up of patients hospitalized for schizophrenia, 1913 to 1940. , 1997, The Journal of nervous and mental disease.

[59]  A. Mackinnon,et al.  Problem of diagnosis in postmortem brain studies of schizophrenia. , 1996, The American journal of psychiatry.

[60]  T. Ashikaga,et al.  The Maine and Vermont Three-Decade Studies of Serious Mental Illness , 1995, British Journal of Psychiatry.

[61]  T. Ashikaga,et al.  The Maine and Vermont Three-Decade Studies of Serious Mental Illness , 1995, British Journal of Psychiatry.

[62]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[63]  Joel Jeffries,et al.  Clinical Handbook of Psychotropic Drugs , 1994 .

[64]  Steven A. Johnson,et al.  Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning , 1992, Neurobiology of Aging.

[65]  T. McGlashan,et al.  Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. , 1991, Archives of general psychiatry.

[66]  T. McGlashan.  A selective review of recent North American long-term followup studies of schizophrenia. , 1988, Schizophrenia bulletin.

[67]  G. Huber,et al.  A LONG‐TERM FOLLOW‐UP STUDY OF SCHIZOPHRENIA: PSYCHIATRIC COURSE OF ILLNESS AND PROGNOSIS , 1975, Acta psychiatrica Scandinavica.